Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the target of a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 1,500 ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Cornell researchers have identified a specific brain circuit that could lead to anxiety treatments without cognitive side ...

Most studies have focused on forms of LTD that are triggered by synaptic activation of either NMDARs (N-methyl-D-aspartate receptors) or metabotropic glutamate receptors (mGluRs). Converging ...

Scientists have pinpointed a brain circuit that, when activated, reduces anxiety without impairing memory. Using ...

Investigators have identified in a preclinical model a specific brain circuit whose inhibition appears to reduce anxiety without side effects. Their work suggests a new target for treating anxiety ...

In their study, published Jan. 28 in Neuron, the researchers examined the effects of experimental drug compounds that activate a type of brain-cell receptor called the metabotropic glutamate receptor ...

In a study published on January 28 in the journal Neuron, the investigators explored how a type of brain receptor called metabotropic glutamate receptor 2 (mGluR2) can be targeted to alleviate ...